View ValuationPolisan Holding 将来の成長Future 基準チェック /06現在、 Polisan Holdingの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長27.5%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesReported Earnings • May 14First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: ₺1.38b (up 2.8% from 1Q 2025). Net loss: ₺336.1m (loss widened 93% from 1Q 2025).お知らせ • Apr 06Polisan Holding A.S., Annual General Meeting, Apr 30, 2026Polisan Holding A.S., Annual General Meeting, Apr 30, 2026. Location: dilovasi organize sanayi bolgesi, 1. kisim, liman caddesi, no:7, dilovasi, kocaeli TurkeyNew Risk • Apr 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change).Board Change • Apr 02Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Director Burcin Muftu was the last director to join the board, commencing their role in 2026. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 12Full year 2025 earnings releasedFull year 2025 results: Revenue: ₺6.40b (up 3.4% from FY 2024). Net loss: ₺889.2m (loss widened 40% from FY 2024).Reported Earnings • Nov 12Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₺1.63b (down 1.2% from 3Q 2024). Net loss: ₺99.2m (loss narrowed 64% from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 166 percentage points per year, which is a significant difference in performance.New Risk • Sep 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Turkish stocks, typically moving 91% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company.New Risk • Jun 24New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₺2.91b (US$73.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₺2.91b market cap, or US$73.4m).Reported Earnings • May 14First quarter 2025 earnings released: ₺0.40 loss per share (vs ₺0.052 profit in 1Q 2024)First quarter 2025 results: ₺0.40 loss per share (down from ₺0.052 profit in 1Q 2024). Revenue: ₺1.45b (up 8.0% from 1Q 2024). Net loss: ₺306.0m (down ₺345.8m from profit in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 66% per year, which means it is well ahead of earnings.New Risk • Apr 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (159% cash payout ratio). Share price has been volatile over the past 3 months (7.6% average weekly change).お知らせ • Mar 27Polisan Holding A.S., Annual General Meeting, Apr 28, 2025Polisan Holding A.S., Annual General Meeting, Apr 28, 2025. Location: dilovasi organize sanayi bolgesi, 1, kisim, liman caddesi, no:7, dilovasi, kocaeli TurkeyReported Earnings • Mar 09Full year 2024 earnings released: ₺0.83 loss per share (vs ₺0.99 profit in FY 2023)Full year 2024 results: ₺0.83 loss per share (down from ₺0.99 profit in FY 2023). Revenue: ₺6.19b (up 11% from FY 2023). Net loss: ₺633.3m (down 185% from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 62% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₺11.94, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 19x in the Chemicals industry in Turkey. Total returns to shareholders of 285% over the past three years.Reported Earnings • Nov 10Third quarter 2024 earnings released: ₺0.36 loss per share (vs ₺0.40 profit in 3Q 2023)Third quarter 2024 results: ₺0.36 loss per share (down from ₺0.40 profit in 3Q 2023). Revenue: ₺1.65b (up 23% from 3Q 2023). Net loss: ₺276.2m (down 190% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Sep 23Polisan Holding A.S.(IBSE:POLHO) dropped from FTSE All-World Index (USD)Polisan Holding A.S.(IBSE:POLHO) dropped from FTSE All-World Index (USD)Reported Earnings • Sep 06Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: ₺1.30b (up 14% from 2Q 2023). Net loss: ₺156.6m (down 270% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Aug 22Polisan Holding A.S. to Report Q2, 2024 Results on Sep 05, 2024Polisan Holding A.S. announced that they will report Q2, 2024 results on Sep 05, 2024Reported Earnings • Jun 05First quarter 2024 earnings released: EPS: ₺0.25 (vs ₺0.016 in 1Q 2023)First quarter 2024 results: EPS: ₺0.25 (up from ₺0.016 in 1Q 2023). Revenue: ₺1.24b (up 20% from 1Q 2023). Net income: ₺186.6m (up ₺174.8m from 1Q 2023). Profit margin: 15% (up from 1.1% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has increased by 66% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 22Polisan Holding A.S. to Report Q1, 2024 Results on Jun 03, 2024Polisan Holding A.S. announced that they will report Q1, 2024 results at 5:30 PM, GTB Standard Time on Jun 03, 2024Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 3 highly experienced directors. CEO & Executive Director Mehmet Hacikamiloglu was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Apr 02Full year 2023 earnings released: EPS: ₺0.99 (vs ₺2.15 in FY 2022)Full year 2023 results: EPS: ₺0.99 (down from ₺2.15 in FY 2022). Revenue: ₺5.60b (up 34% from FY 2022). Net income: ₺747.7m (down 54% from FY 2022). Profit margin: 13% (down from 39% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 70% per year whereas the company’s share price has increased by 67% per year.Valuation Update With 7 Day Price Move • Mar 29Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₺15.32, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 23x in the Chemicals industry in Turkey. Total returns to shareholders of 388% over the past three years.Valuation Update With 7 Day Price Move • Dec 22Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₺11.30, the stock trades at a trailing P/E ratio of 5.4x. Average trailing P/E is 19x in the Chemicals industry in Turkey. Total returns to shareholders of 190% over the past three years.New Risk • Nov 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (29% accrual ratio). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (10% average weekly change).Valuation Update With 7 Day Price Move • Nov 21Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₺16.08, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 21x in the Chemicals industry in Turkey. Total returns to shareholders of 330% over the past three years.Reported Earnings • Nov 02Third quarter 2023 earnings released: EPS: ₺0.40 (vs ₺0.17 in 3Q 2022)Third quarter 2023 results: EPS: ₺0.40 (up from ₺0.17 in 3Q 2022). Revenue: ₺1.34b (up 11% from 3Q 2022). Net income: ₺305.9m (up 133% from 3Q 2022). Profit margin: 23% (up from 11% in 3Q 2022). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 55% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Oct 20Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₺12.58, the stock trades at a trailing P/E ratio of 6.7x. Average trailing P/E is 22x in the Chemicals industry in Turkey. Total returns to shareholders of 221% over the past three years.Valuation Update With 7 Day Price Move • Sep 07Investor sentiment improves as stock rises 36%After last week's 36% share price gain to ₺17.93, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 20x in the Chemicals industry in Turkey. Total returns to shareholders of 542% over the past three years.Reported Earnings • Aug 06Second quarter 2023 earnings released: EPS: ₺0.12 (vs ₺0.24 in 2Q 2022)Second quarter 2023 results: EPS: ₺0.12 (down from ₺0.24 in 2Q 2022). Revenue: ₺1.14b (flat on 2Q 2022). Net income: ₺92.1m (down 50% from 2Q 2022). Profit margin: 8.1% (down from 16% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 58% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 31Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₺8.63, the stock trades at a trailing P/E ratio of 4.3x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 208% over the past three years.Reported Earnings • May 07First quarter 2023 earnings released: EPS: ₺0.016 (vs ₺0.17 in 1Q 2022)First quarter 2023 results: EPS: ₺0.016 (down from ₺0.17 in 1Q 2022). Revenue: ₺1.03b (up 25% from 1Q 2022). Net income: ₺11.8m (down 91% from 1Q 2022). Profit margin: 1.1% (down from 16% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 55% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₺9.53, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 10x in the Chemicals industry in Turkey. Total returns to shareholders of 310% over the past three years.Upcoming Dividend • Mar 29Upcoming dividend of ₺0.40 per share at 3.4% yieldEligible shareholders must have bought the stock before 05 April 2023. Payment date: 07 April 2023. Payout ratio is a comfortable 18% and this is well supported by cash flows. Trailing yield: 3.4%. Within top quartile of Turkish dividend payers (3.2%). Higher than average of industry peers (2.0%).Reported Earnings • Mar 03Full year 2022 earnings released: EPS: ₺2.15 (vs ₺0.37 in FY 2021)Full year 2022 results: EPS: ₺2.15 (up from ₺0.37 in FY 2021). Revenue: ₺4.20b (up 113% from FY 2021). Net income: ₺1.63b (up 483% from FY 2021). Profit margin: 39% (up from 14% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 61% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Feb 16Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₺9.27, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 222% over the past three years.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₺8.59, the stock trades at a trailing P/E ratio of 10.8x. Average trailing P/E is 13x in the Chemicals industry in Turkey. Total returns to shareholders of 159% over the past three years.Valuation Update With 7 Day Price Move • Jan 05Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₺11.66, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 16x in the Chemicals industry in Turkey. Total returns to shareholders of 290% over the past three years.Reported Earnings • Nov 02Third quarter 2022 earnings released: EPS: ₺0.17 (vs ₺0.06 in 3Q 2021)Third quarter 2022 results: EPS: ₺0.17 (up from ₺0.06 in 3Q 2021). Revenue: ₺1.22b (up 136% from 3Q 2021). Net income: ₺131.2m (up 190% from 3Q 2021). Profit margin: 11% (up from 8.8% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 53% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Oct 27Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₺9.81, the stock trades at a trailing P/E ratio of 14.4x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 290% over the past three years.Valuation Update With 7 Day Price Move • Oct 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺7.71, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 178% over the past three years.Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₺6.79, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 213% over the past three years.Reported Earnings • Aug 10Second quarter 2022 earnings released: EPS: ₺0.24 (vs ₺0.054 in 2Q 2021)Second quarter 2022 results: EPS: ₺0.24 (up from ₺0.054 in 2Q 2021). Revenue: ₺1.14b (up 164% from 2Q 2021). Net income: ₺185.8m (up 355% from 2Q 2021). Profit margin: 16% (up from 9.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jul 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺5.65, the stock trades at a trailing P/E ratio of 11.5x. Average trailing P/E is 15x in the Chemicals industry in Turkey. Total returns to shareholders of 156% over the past three years.Valuation Update With 7 Day Price Move • May 24Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺4.47, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 115% over the past three years.Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₺3.63, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 16x in the Chemicals industry in Turkey. Total returns to shareholders of 17% over the past three years.Reported Earnings • Apr 29First quarter 2022 earnings released: EPS: ₺0.17 (vs ₺0.051 in 1Q 2021)First quarter 2022 results: EPS: ₺0.17 (up from ₺0.051 in 1Q 2021). Revenue: ₺826.1m (up 133% from 1Q 2021). Net income: ₺131.2m (up 238% from 1Q 2021). Profit margin: 16% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 7 non-independent directors. Independent Director Esra Yazici was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Apr 05Upcoming dividend of ₺0.02 per shareEligible shareholders must have bought the stock before 12 April 2022. Payment date: 14 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.7%). Lower than average of industry peers (0.8%).Upcoming Dividend • Mar 30Upcoming dividend of ₺0.02 per shareEligible shareholders must have bought the stock before 06 April 2022. Payment date: 08 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.9%). Lower than average of industry peers (0.7%).Reported Earnings • Mar 09Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ₺0.37 (up from ₺0.17 in FY 2020). Revenue: ₺1.97b (up 87% from FY 2020). Net income: ₺279.9m (up 121% from FY 2020). Profit margin: 14% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 05Third quarter 2021 earnings releasedThe company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₺515.2m (up 81% from 3Q 2020). Net income: ₺45.2m (up 168% from 3Q 2020). Profit margin: 8.8% (up from 5.9% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 13Second quarter 2021 earnings released: EPS ₺0.054 (vs ₺0.029 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₺431.1m (up 85% from 2Q 2020). Net income: ₺40.8m (up 85% from 2Q 2020). Profit margin: 9.5% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Upcoming Dividend • Mar 30Upcoming dividend of ₺0.013 per shareEligible shareholders must have bought the stock before 06 April 2021. Payment date: 08 April 2021. Trailing yield: 0.3%. Lower than top quartile of Turkish dividend payers (2.7%). Lower than average of industry peers (1.6%).Valuation Update With 7 Day Price Move • Mar 22Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₺3.19, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 35x in the Chemicals industry in Turkey. Total returns to shareholders of 4.1% over the past three years.Reported Earnings • Mar 12Full year 2020 earnings released: EPS ₺0.17 (vs ₺0.086 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₺1.05b (up 3.8% from FY 2019). Net income: ₺126.6m (up 94% from FY 2019). Profit margin: 12% (up from 6.4% in FY 2019). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 4% per year.Is New 90 Day High Low • Feb 24New 90-day low: ₺3.65The company is down 7.0% from its price of ₺3.92 on 26 November 2020. The Turkish market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 65% over the same period.Is New 90 Day High Low • Jan 25New 90-day high: ₺4.32The company is up 17% from its price of ₺3.70 on 27 October 2020. The Turkish market is up 24% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 64% over the same period.Reported Earnings • Nov 01Third quarter earnings releasedOver the last 12 months the company has reported total profits of ₺72.2m, up 64% from the prior year. Total revenue was ₺990.2m over the last 12 months, down 11% from the prior year.Is New 90 Day High Low • Oct 05New 90-day high: ₺3.38The company is up 3.0% from its price of ₺3.28 on 07 July 2020. The Turkish market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Polisan Holding は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測IBSE:POLHO - アナリストの将来予測と過去の財務データ ( )TRY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/20266,124-1,0103161,003N/A12/31/20256,402-889-432354N/A9/30/20255,557-675191969N/A6/30/20255,739-86858759N/A3/31/20255,865-1,110-73145N/A12/31/20247,095-422-204710N/A9/30/20247,310915-403280N/A6/30/20247,3471,251-271380N/A3/31/20247,8291,4449291,483N/A12/31/20238,0901,0808481,344N/A9/30/202310,5121,6001,0811,563N/A6/30/20239,8811,6881,2711,778N/A3/31/20238,7221,9899681,372N/A12/31/20227,6122,182433867N/A9/30/20223,846603216507N/A6/30/20223,146517-101119N/A3/31/20222,44037265228N/A12/31/20211,969280203320N/A9/30/20211,60220468148N/A6/30/20211,372176180236N/A3/31/20211,173157185232N/A12/31/20201,051127178224N/A9/30/202099072237298N/A6/30/202096790182247N/A3/31/20201,01393147226N/A12/31/20191,01365N/A206N/A9/30/20191,11244N/A112N/A6/30/20191,176-9N/A180N/A3/31/20191,169-10N/A204N/A12/31/20181,16328N/A169N/A9/30/20181,01765N/A201N/A6/30/2018890101N/A70N/A3/31/2018815101N/A-9N/A12/31/201775099N/A-31N/A9/30/2017690513N/A163N/A6/30/2017607499N/A176N/A3/31/2017527484N/A200N/A12/31/2016470469N/A205N/A9/30/20165746N/A47N/A6/30/201619823N/A85N/A3/31/201634523N/A55N/A12/31/201543421N/A33N/A9/30/201586820N/A76N/A6/30/201580339N/A63N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: POLHOの予測収益成長が 貯蓄率 ( 22.4% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: POLHOの収益がTR市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: POLHOの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: POLHOの収益がTR市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: POLHOの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: POLHOの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 04:30終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Polisan Holding A.S. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Kenan TuranYatirim Finansman Menkul Degerler A.S.
Reported Earnings • May 14First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: ₺1.38b (up 2.8% from 1Q 2025). Net loss: ₺336.1m (loss widened 93% from 1Q 2025).
お知らせ • Apr 06Polisan Holding A.S., Annual General Meeting, Apr 30, 2026Polisan Holding A.S., Annual General Meeting, Apr 30, 2026. Location: dilovasi organize sanayi bolgesi, 1. kisim, liman caddesi, no:7, dilovasi, kocaeli Turkey
New Risk • Apr 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change).
Board Change • Apr 02Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Director Burcin Muftu was the last director to join the board, commencing their role in 2026. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 12Full year 2025 earnings releasedFull year 2025 results: Revenue: ₺6.40b (up 3.4% from FY 2024). Net loss: ₺889.2m (loss widened 40% from FY 2024).
Reported Earnings • Nov 12Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₺1.63b (down 1.2% from 3Q 2024). Net loss: ₺99.2m (loss narrowed 64% from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 166 percentage points per year, which is a significant difference in performance.
New Risk • Sep 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Turkish stocks, typically moving 91% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company.
New Risk • Jun 24New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₺2.91b (US$73.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₺2.91b market cap, or US$73.4m).
Reported Earnings • May 14First quarter 2025 earnings released: ₺0.40 loss per share (vs ₺0.052 profit in 1Q 2024)First quarter 2025 results: ₺0.40 loss per share (down from ₺0.052 profit in 1Q 2024). Revenue: ₺1.45b (up 8.0% from 1Q 2024). Net loss: ₺306.0m (down ₺345.8m from profit in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 66% per year, which means it is well ahead of earnings.
New Risk • Apr 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (159% cash payout ratio). Share price has been volatile over the past 3 months (7.6% average weekly change).
お知らせ • Mar 27Polisan Holding A.S., Annual General Meeting, Apr 28, 2025Polisan Holding A.S., Annual General Meeting, Apr 28, 2025. Location: dilovasi organize sanayi bolgesi, 1, kisim, liman caddesi, no:7, dilovasi, kocaeli Turkey
Reported Earnings • Mar 09Full year 2024 earnings released: ₺0.83 loss per share (vs ₺0.99 profit in FY 2023)Full year 2024 results: ₺0.83 loss per share (down from ₺0.99 profit in FY 2023). Revenue: ₺6.19b (up 11% from FY 2023). Net loss: ₺633.3m (down 185% from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 62% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₺11.94, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 19x in the Chemicals industry in Turkey. Total returns to shareholders of 285% over the past three years.
Reported Earnings • Nov 10Third quarter 2024 earnings released: ₺0.36 loss per share (vs ₺0.40 profit in 3Q 2023)Third quarter 2024 results: ₺0.36 loss per share (down from ₺0.40 profit in 3Q 2023). Revenue: ₺1.65b (up 23% from 3Q 2023). Net loss: ₺276.2m (down 190% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Sep 23Polisan Holding A.S.(IBSE:POLHO) dropped from FTSE All-World Index (USD)Polisan Holding A.S.(IBSE:POLHO) dropped from FTSE All-World Index (USD)
Reported Earnings • Sep 06Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: ₺1.30b (up 14% from 2Q 2023). Net loss: ₺156.6m (down 270% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Aug 22Polisan Holding A.S. to Report Q2, 2024 Results on Sep 05, 2024Polisan Holding A.S. announced that they will report Q2, 2024 results on Sep 05, 2024
Reported Earnings • Jun 05First quarter 2024 earnings released: EPS: ₺0.25 (vs ₺0.016 in 1Q 2023)First quarter 2024 results: EPS: ₺0.25 (up from ₺0.016 in 1Q 2023). Revenue: ₺1.24b (up 20% from 1Q 2023). Net income: ₺186.6m (up ₺174.8m from 1Q 2023). Profit margin: 15% (up from 1.1% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has increased by 66% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 22Polisan Holding A.S. to Report Q1, 2024 Results on Jun 03, 2024Polisan Holding A.S. announced that they will report Q1, 2024 results at 5:30 PM, GTB Standard Time on Jun 03, 2024
Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 3 highly experienced directors. CEO & Executive Director Mehmet Hacikamiloglu was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Apr 02Full year 2023 earnings released: EPS: ₺0.99 (vs ₺2.15 in FY 2022)Full year 2023 results: EPS: ₺0.99 (down from ₺2.15 in FY 2022). Revenue: ₺5.60b (up 34% from FY 2022). Net income: ₺747.7m (down 54% from FY 2022). Profit margin: 13% (down from 39% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 70% per year whereas the company’s share price has increased by 67% per year.
Valuation Update With 7 Day Price Move • Mar 29Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₺15.32, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 23x in the Chemicals industry in Turkey. Total returns to shareholders of 388% over the past three years.
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₺11.30, the stock trades at a trailing P/E ratio of 5.4x. Average trailing P/E is 19x in the Chemicals industry in Turkey. Total returns to shareholders of 190% over the past three years.
New Risk • Nov 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (29% accrual ratio). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (10% average weekly change).
Valuation Update With 7 Day Price Move • Nov 21Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₺16.08, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 21x in the Chemicals industry in Turkey. Total returns to shareholders of 330% over the past three years.
Reported Earnings • Nov 02Third quarter 2023 earnings released: EPS: ₺0.40 (vs ₺0.17 in 3Q 2022)Third quarter 2023 results: EPS: ₺0.40 (up from ₺0.17 in 3Q 2022). Revenue: ₺1.34b (up 11% from 3Q 2022). Net income: ₺305.9m (up 133% from 3Q 2022). Profit margin: 23% (up from 11% in 3Q 2022). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 55% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Oct 20Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₺12.58, the stock trades at a trailing P/E ratio of 6.7x. Average trailing P/E is 22x in the Chemicals industry in Turkey. Total returns to shareholders of 221% over the past three years.
Valuation Update With 7 Day Price Move • Sep 07Investor sentiment improves as stock rises 36%After last week's 36% share price gain to ₺17.93, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 20x in the Chemicals industry in Turkey. Total returns to shareholders of 542% over the past three years.
Reported Earnings • Aug 06Second quarter 2023 earnings released: EPS: ₺0.12 (vs ₺0.24 in 2Q 2022)Second quarter 2023 results: EPS: ₺0.12 (down from ₺0.24 in 2Q 2022). Revenue: ₺1.14b (flat on 2Q 2022). Net income: ₺92.1m (down 50% from 2Q 2022). Profit margin: 8.1% (down from 16% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 58% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 31Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₺8.63, the stock trades at a trailing P/E ratio of 4.3x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 208% over the past three years.
Reported Earnings • May 07First quarter 2023 earnings released: EPS: ₺0.016 (vs ₺0.17 in 1Q 2022)First quarter 2023 results: EPS: ₺0.016 (down from ₺0.17 in 1Q 2022). Revenue: ₺1.03b (up 25% from 1Q 2022). Net income: ₺11.8m (down 91% from 1Q 2022). Profit margin: 1.1% (down from 16% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 55% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₺9.53, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 10x in the Chemicals industry in Turkey. Total returns to shareholders of 310% over the past three years.
Upcoming Dividend • Mar 29Upcoming dividend of ₺0.40 per share at 3.4% yieldEligible shareholders must have bought the stock before 05 April 2023. Payment date: 07 April 2023. Payout ratio is a comfortable 18% and this is well supported by cash flows. Trailing yield: 3.4%. Within top quartile of Turkish dividend payers (3.2%). Higher than average of industry peers (2.0%).
Reported Earnings • Mar 03Full year 2022 earnings released: EPS: ₺2.15 (vs ₺0.37 in FY 2021)Full year 2022 results: EPS: ₺2.15 (up from ₺0.37 in FY 2021). Revenue: ₺4.20b (up 113% from FY 2021). Net income: ₺1.63b (up 483% from FY 2021). Profit margin: 39% (up from 14% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 61% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Feb 16Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₺9.27, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 222% over the past three years.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₺8.59, the stock trades at a trailing P/E ratio of 10.8x. Average trailing P/E is 13x in the Chemicals industry in Turkey. Total returns to shareholders of 159% over the past three years.
Valuation Update With 7 Day Price Move • Jan 05Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₺11.66, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 16x in the Chemicals industry in Turkey. Total returns to shareholders of 290% over the past three years.
Reported Earnings • Nov 02Third quarter 2022 earnings released: EPS: ₺0.17 (vs ₺0.06 in 3Q 2021)Third quarter 2022 results: EPS: ₺0.17 (up from ₺0.06 in 3Q 2021). Revenue: ₺1.22b (up 136% from 3Q 2021). Net income: ₺131.2m (up 190% from 3Q 2021). Profit margin: 11% (up from 8.8% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 53% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Oct 27Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₺9.81, the stock trades at a trailing P/E ratio of 14.4x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 290% over the past three years.
Valuation Update With 7 Day Price Move • Oct 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺7.71, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 178% over the past three years.
Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₺6.79, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 213% over the past three years.
Reported Earnings • Aug 10Second quarter 2022 earnings released: EPS: ₺0.24 (vs ₺0.054 in 2Q 2021)Second quarter 2022 results: EPS: ₺0.24 (up from ₺0.054 in 2Q 2021). Revenue: ₺1.14b (up 164% from 2Q 2021). Net income: ₺185.8m (up 355% from 2Q 2021). Profit margin: 16% (up from 9.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jul 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺5.65, the stock trades at a trailing P/E ratio of 11.5x. Average trailing P/E is 15x in the Chemicals industry in Turkey. Total returns to shareholders of 156% over the past three years.
Valuation Update With 7 Day Price Move • May 24Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺4.47, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 115% over the past three years.
Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₺3.63, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 16x in the Chemicals industry in Turkey. Total returns to shareholders of 17% over the past three years.
Reported Earnings • Apr 29First quarter 2022 earnings released: EPS: ₺0.17 (vs ₺0.051 in 1Q 2021)First quarter 2022 results: EPS: ₺0.17 (up from ₺0.051 in 1Q 2021). Revenue: ₺826.1m (up 133% from 1Q 2021). Net income: ₺131.2m (up 238% from 1Q 2021). Profit margin: 16% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 7 non-independent directors. Independent Director Esra Yazici was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Apr 05Upcoming dividend of ₺0.02 per shareEligible shareholders must have bought the stock before 12 April 2022. Payment date: 14 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.7%). Lower than average of industry peers (0.8%).
Upcoming Dividend • Mar 30Upcoming dividend of ₺0.02 per shareEligible shareholders must have bought the stock before 06 April 2022. Payment date: 08 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.9%). Lower than average of industry peers (0.7%).
Reported Earnings • Mar 09Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ₺0.37 (up from ₺0.17 in FY 2020). Revenue: ₺1.97b (up 87% from FY 2020). Net income: ₺279.9m (up 121% from FY 2020). Profit margin: 14% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 05Third quarter 2021 earnings releasedThe company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₺515.2m (up 81% from 3Q 2020). Net income: ₺45.2m (up 168% from 3Q 2020). Profit margin: 8.8% (up from 5.9% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 13Second quarter 2021 earnings released: EPS ₺0.054 (vs ₺0.029 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₺431.1m (up 85% from 2Q 2020). Net income: ₺40.8m (up 85% from 2Q 2020). Profit margin: 9.5% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Mar 30Upcoming dividend of ₺0.013 per shareEligible shareholders must have bought the stock before 06 April 2021. Payment date: 08 April 2021. Trailing yield: 0.3%. Lower than top quartile of Turkish dividend payers (2.7%). Lower than average of industry peers (1.6%).
Valuation Update With 7 Day Price Move • Mar 22Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₺3.19, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 35x in the Chemicals industry in Turkey. Total returns to shareholders of 4.1% over the past three years.
Reported Earnings • Mar 12Full year 2020 earnings released: EPS ₺0.17 (vs ₺0.086 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₺1.05b (up 3.8% from FY 2019). Net income: ₺126.6m (up 94% from FY 2019). Profit margin: 12% (up from 6.4% in FY 2019). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 4% per year.
Is New 90 Day High Low • Feb 24New 90-day low: ₺3.65The company is down 7.0% from its price of ₺3.92 on 26 November 2020. The Turkish market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 65% over the same period.
Is New 90 Day High Low • Jan 25New 90-day high: ₺4.32The company is up 17% from its price of ₺3.70 on 27 October 2020. The Turkish market is up 24% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 64% over the same period.
Reported Earnings • Nov 01Third quarter earnings releasedOver the last 12 months the company has reported total profits of ₺72.2m, up 64% from the prior year. Total revenue was ₺990.2m over the last 12 months, down 11% from the prior year.
Is New 90 Day High Low • Oct 05New 90-day high: ₺3.38The company is up 3.0% from its price of ₺3.28 on 07 July 2020. The Turkish market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period.